Projecting the number of patients with end-stage renal disease in the United States to the year 2015

被引:286
作者
Gilbertson, DT
Liu, JN
Xue, JL
Louis, TA
Solid, CA
Ebben, JP
Collins, AJ
机构
[1] US Renal Data Syst, Coordinating Ctr, Minneapolis, MN 55404 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 12期
关键词
D O I
10.1681/ASN.2005010112
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The size of the prevalent ESRD population in the United States increased dramatically during the 1990s, from 196,000 in 1991 to 382,000 in 2000. Incidence also increased considerably during the same period, from 53,000 to 93,000 per year. If previous trends in ESRD incidence and prevalence continue, then current levels of health care resources that are devoted to the care of these patients will eventually be unable to meet the demand. This study discusses a Markov model developed to predict ESRD incidence, prevalence, and mortality to the year 2015 and incorporating expected changes in age/race distributions, diabetes prevalence, ESRD incidence, and probability of death. The model predicted that by 2015 there will be 136,166 incident ESRD patients per year (lower/upper limits 110,989 to 164,550), 712,290 prevalent patients (595,046 to 842,761), and 107,760 ESRD deaths annually (96,068 to 118,220). Incidence and prevalence counts are expected to increase by 44 and 85%, respectively, from 2000 to 2015 and incidence and prevalence rates per million population by 32 and 70%, respectively. The financial and human resources that will be needed to care for these patients in 2015 will be considerably greater than in 2005.
引用
收藏
页码:3736 / 3741
页数:6
相关论文
共 19 条
[1]   Projection of diabetes burden through 2050 - Impact of changing demography and disease prevalence in the US [J].
Boyle, JP ;
Honeycutt, AA ;
Narayan, KMV ;
Hoerger, TJ ;
Geiss, LS ;
Chen, H ;
Thompson, TJ .
DIABETES CARE, 2001, 24 (11) :1936-1940
[2]   Predicting the future demand for renal replacement therapy in England using simulation modelling [J].
Davies, R ;
Roderick, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (12) :2512-2516
[3]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[4]   Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 [J].
Mokdad, AH ;
Ford, ES ;
Bowman, BA ;
Dietz, WH ;
Vinicor, F ;
Bales, VS ;
Marks, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (01) :76-79
[5]   The continuing epidemics of obesity and diabetes in the United States [J].
Mokdad, AH ;
Bowman, BA ;
Ford, ES ;
Vinicor, F ;
Marks, JS ;
Koplan, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (10) :1195-1200
[6]   Diabetes trends in the US: 1990-1998 [J].
Mokdad, AH ;
Ford, ES ;
Bowman, BA ;
Nelson, DE ;
Engelgau, MM ;
Vinicor, F ;
Marks, JS .
DIABETES CARE, 2000, 23 (09) :1278-1283
[7]  
Molzahn M, 1996, NEPHROL DIAL TRANSPL, V11, P59
[8]   PREDICTION OF END-STAGE RENAL-DISEASE PATIENT POPULATION IN JAPAN BY SYSTEM DYNAMICS MODEL [J].
MOTOHASHI, Y ;
NISHI, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (04) :1032-1036
[9]  
PORT FK, 2005, KIDNEY INT S, V50, pS3
[10]   Simulation model of renal replacement therapy: predicting future demand in England [J].
Roderick, P ;
Davies, R ;
Jones, C ;
Feest, T ;
Smith, S ;
Farrington, K .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (03) :692-701